Objective:To explore the relationship between treatment compliance,treatment attitude and belief,and quality of life in patients with hypertension in the community,and to provide evidence for improving their quality o...Objective:To explore the relationship between treatment compliance,treatment attitude and belief,and quality of life in patients with hypertension in the community,and to provide evidence for improving their quality of life.Methods:A convenient sampling method was used to survey 250 patients with hypertension who met the inclusion criteria using the General Questionnaire,Treatment compliance,Treatment Attitudes and Beliefs,and Quality of Life Scale.Results:The total score of treatment compliance of hypertension patients in the community was(91.678±11.431),treatment attitude and belief score(70.407±9.008),quality of life score(113.599±13.511),Pearson correlation analysis showed that the treatment compliance of hypertension patients was positively correlated with quality of life(r=0.433,P<0.01),and treatment attitude and belief were positively correlated with quality of life(r=0.463,P<0.01).Conclusion:The quality of life of patients with hypertension in the community is related to treatment compliance and treatment attitudes and beliefs.展开更多
About half of the patients diagnosed with bipolar disorder(BD) become non-adherent during longterm treatment, a rate largely similar to other chronic illnesses and one that has remained unchanged over the years. Non-a...About half of the patients diagnosed with bipolar disorder(BD) become non-adherent during longterm treatment, a rate largely similar to other chronic illnesses and one that has remained unchanged over the years. Non-adherence in BD is a complex phenomenon determined by a multitude of influences. However, thereis considerable uncertainty about the key determinants of non-adherence in BD. Initial research on nonadherence in BD mostly limited itself to examining demographic, clinical and medication-related factors impacting adherence. However, because of inconsistent results and failure of these studies to address the complexities of adherence behaviour, demographic and illness-related factors were alone unable to explain or predict non-adherence in BD. This prompted a shift to a more patient-centred approach of viewing nonadherence. The central element of this approach includes an emphasis on patients' decisions regarding their own treatment based on their personal beliefs, life circumstances and their perceptions of benefits and disadvantages of treatment. Patients' decisionmaking processes are influenced by the nature of their relationship with clinicians and the health-care system and by people in their immediate environment. The primacy of the patient's perspective on non-adherence is in keeping with the current theoretical models and concordance-based approaches to adherence behaviour in BD. Research over the past two decades has further endorsed the critical role of patients' attitudes and beliefs regarding medications, the importance of a collaborative treatment-alliance, the influence of the family, and the significance of other patient-related factors such as knowledge, stigma, patient satisfaction and access to treatment in determining non-adherence in BD. Though simply moving from an illness-centred to a patientcentred approach is unlikely to solve the problem of nonadherence in BD, such an approach is more likely to lead to a better understanding of non-adherence and more likely to yield effective solutions to tackle this common and distressing problem afflicting patients with BD.展开更多
基金This study was approved by Shaanxi Provincial Key Research and Development Program(2017SF-294).
文摘Objective:To explore the relationship between treatment compliance,treatment attitude and belief,and quality of life in patients with hypertension in the community,and to provide evidence for improving their quality of life.Methods:A convenient sampling method was used to survey 250 patients with hypertension who met the inclusion criteria using the General Questionnaire,Treatment compliance,Treatment Attitudes and Beliefs,and Quality of Life Scale.Results:The total score of treatment compliance of hypertension patients in the community was(91.678±11.431),treatment attitude and belief score(70.407±9.008),quality of life score(113.599±13.511),Pearson correlation analysis showed that the treatment compliance of hypertension patients was positively correlated with quality of life(r=0.433,P<0.01),and treatment attitude and belief were positively correlated with quality of life(r=0.463,P<0.01).Conclusion:The quality of life of patients with hypertension in the community is related to treatment compliance and treatment attitudes and beliefs.
文摘About half of the patients diagnosed with bipolar disorder(BD) become non-adherent during longterm treatment, a rate largely similar to other chronic illnesses and one that has remained unchanged over the years. Non-adherence in BD is a complex phenomenon determined by a multitude of influences. However, thereis considerable uncertainty about the key determinants of non-adherence in BD. Initial research on nonadherence in BD mostly limited itself to examining demographic, clinical and medication-related factors impacting adherence. However, because of inconsistent results and failure of these studies to address the complexities of adherence behaviour, demographic and illness-related factors were alone unable to explain or predict non-adherence in BD. This prompted a shift to a more patient-centred approach of viewing nonadherence. The central element of this approach includes an emphasis on patients' decisions regarding their own treatment based on their personal beliefs, life circumstances and their perceptions of benefits and disadvantages of treatment. Patients' decisionmaking processes are influenced by the nature of their relationship with clinicians and the health-care system and by people in their immediate environment. The primacy of the patient's perspective on non-adherence is in keeping with the current theoretical models and concordance-based approaches to adherence behaviour in BD. Research over the past two decades has further endorsed the critical role of patients' attitudes and beliefs regarding medications, the importance of a collaborative treatment-alliance, the influence of the family, and the significance of other patient-related factors such as knowledge, stigma, patient satisfaction and access to treatment in determining non-adherence in BD. Though simply moving from an illness-centred to a patientcentred approach is unlikely to solve the problem of nonadherence in BD, such an approach is more likely to lead to a better understanding of non-adherence and more likely to yield effective solutions to tackle this common and distressing problem afflicting patients with BD.
